Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)
One hundred and one patients with disseminated ovarian cancer (OC) treated at Surgery Department Eight, Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, in 1998–2007 and continued to be followed up and treated till March 2012...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849403708207529984 |
|---|---|
| author | N. G. Kormosh K. P. Laktionov A. N. Gritsai N. S. Kerzhkovskaya |
| author_facet | N. G. Kormosh K. P. Laktionov A. N. Gritsai N. S. Kerzhkovskaya |
| author_sort | N. G. Kormosh |
| collection | DOAJ |
| description | One hundred and one patients with disseminated ovarian cancer (OC) treated at Surgery Department Eight, Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, in 1998–2007 and continued to be followed up and treated till March 2012 were examined to make a clinical analysis of the course of the disease. Median follow-up was 32 months. The proportion of patients with Stages III–IV OC was 87 %. Optimal cytoreductive surgery was shown to be possible in 21 (20.8 %) patients dur- ing Stage 1 combination therapy and in 20 (19.8 %) patients after neoadjuvant chemotherapy (CT). The maximum survival rates (with a median of 87.7 months) were achieved in 21 patients who had undergone optimal surgery and had a tumor that is highly susceptible to CT with platinum derivatives. It is concluded that it is necessary to improve the diagnosis of the disease for increasing treatment results. |
| format | Article |
| id | doaj-art-c6055e470c2e4f4cae27a65746ea9e3e |
| institution | Kabale University |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| publishDate | 2014-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj-art-c6055e470c2e4f4cae27a65746ea9e3e2025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0103-415115910.17650/1994-4098-2012-0-3-4-151-159147Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)N. G. Kormosh0K. P. Laktionov1A. N. Gritsai2N. S. Kerzhkovskaya3N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowOne hundred and one patients with disseminated ovarian cancer (OC) treated at Surgery Department Eight, Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, in 1998–2007 and continued to be followed up and treated till March 2012 were examined to make a clinical analysis of the course of the disease. Median follow-up was 32 months. The proportion of patients with Stages III–IV OC was 87 %. Optimal cytoreductive surgery was shown to be possible in 21 (20.8 %) patients dur- ing Stage 1 combination therapy and in 20 (19.8 %) patients after neoadjuvant chemotherapy (CT). The maximum survival rates (with a median of 87.7 months) were achieved in 21 patients who had undergone optimal surgery and had a tumor that is highly susceptible to CT with platinum derivatives. It is concluded that it is necessary to improve the diagnosis of the disease for increasing treatment results.https://ojrs.abvpress.ru/ojrs/article/view/131neoadjuvant ctovarian canceroptimal cytoreductive surgery |
| spellingShingle | N. G. Kormosh K. P. Laktionov A. N. Gritsai N. S. Kerzhkovskaya Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience) Опухоли женской репродуктивной системы neoadjuvant ct ovarian cancer optimal cytoreductive surgery |
| title | Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience) |
| title_full | Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience) |
| title_fullStr | Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience) |
| title_full_unstemmed | Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience) |
| title_short | Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience) |
| title_sort | optimal cytoreductive surgery in patients with disseminated ovarian cancer the department s experience |
| topic | neoadjuvant ct ovarian cancer optimal cytoreductive surgery |
| url | https://ojrs.abvpress.ru/ojrs/article/view/131 |
| work_keys_str_mv | AT ngkormosh optimalcytoreductivesurgeryinpatientswithdisseminatedovariancancerthedepartmentsexperience AT kplaktionov optimalcytoreductivesurgeryinpatientswithdisseminatedovariancancerthedepartmentsexperience AT angritsai optimalcytoreductivesurgeryinpatientswithdisseminatedovariancancerthedepartmentsexperience AT nskerzhkovskaya optimalcytoreductivesurgeryinpatientswithdisseminatedovariancancerthedepartmentsexperience |